Plain-English translation of NCT04295473 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer, less-invasive surgical technique for stomach cancer — called reduced port laparoscopic gastrectomy, which uses only 1–3 small surgical openings — works as well as or better than the standard laparoscopic approach, which uses 5 openings. Researchers will compare how quickly patients recover, how many complications occur, and how long patients survive after each type of surgery.
The newer technique with fewer surgical openings might cause less pain, faster recovery, and fewer complications, but doctors need to prove it is as safe and effective as the standard approach before recommending it widely.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will receive laparoscopic gastrectomy surgery — minimally invasive stomach cancer surgery — using one of two techniques. Your surgical team will assign you to receive either the newer reduced-port approach (1–3 small openings) or the standard approach (5 openings). After surgery, researchers will track your recovery, any complications, nutrition status, and long-term survival over time.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
China
Sponsor
Nanchong Central Hospital
Enrollment target
~160 participants
Started
March 2020
Primary completion
March 2027
Age range
18 Years – 90 Years
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yunhong Tian, MD
Nanchong Central Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.